Introduction
============

In the United States, African American individuals have a higher prevalence and severity of hypertension, and develop hypertension at an earlier age than Caucasian individuals ([@B52]; [@B14]). Furthermore, African American adults have greater rates of premature hypertensive complications such as chronic kidney disease, stroke, and coronary heart disease ([@B52]; [@B14]). The relation between dietary salt and BP is well established ([@B2]; [@B18]) and African American individuals have been shown to be more prone to the adverse cardiovascular effects of chronic high dietary salt although the mechanisms for these disparities remain to be fully elucidated ([@B52]; [@B9]).

Increased dietary salt intake can elicit small, but consequential changes in plasma sodium (Na^+^) concentration ([@B21]; [@B20]) and small changes in plasma Na^+^ are associated with elevated BP and vascular dysfunction ([@B8], [@B7]; [@B42]; [@B29]). The RAAS is comprised of fluid regulatory hormones that directly control Na^+^ excretion by the kidneys. Increased RAAS activation contributes to greater Na^+^ reabsorption ([@B17]). African American individuals have lower basal PRA and Aldo levels ([@B26]; [@B16]; [@B28]; [@B34]; [@B22], [@B23]; [@B33]). Therefore, lower baseline levels of RAAS hormones may decrease African American individuals' ability to buffer acute Na^+^ challenges and regulate BP. This is important because altered BP and RAAS hormone responses may partially explain why African American adults are at a greater risk for experiencing adverse cardiovascular effects with high dietary salt. However, previous studies examining the role of RAAS on the racial differences to salt have primarily been done in hypertensive adults ([@B19]) or have not accounted for baseline differences in RAAS when comparing responses to salt manipulation ([@B27]).

We have previously used HSI (3% NaCl) to acutely increase serum Na^+^ and have found increased sympathetic nerve activity and altered baroreflex regulation of BP control ([@B10], [@B11]; [@B50]; [@B15]). These findings do not occur with isovolumic isotonic saline infusion, suggesting the relation between serum Na^+^ concentration and BP is independent of sodium-induced expansion of the extracellular fluid volume ([@B10], [@B11]). However, it remains unknown if there is racial difference in BP responsiveness to a given change in serum Na^+^ level. Accordingly, the purpose of the present study was to determine whether serum Na^+^, BP, and RAAS responses to an acute Na^+^ and volume load via HSI differ between young, normotensive African American and Caucasian adults. We hypothesized that African American individuals would have greater BP responsiveness for a given change in serum Na^+^. We also hypothesized lower basal levels of RAAS in African American individuals would contribute to a lesser reduction in the RAAS in response to the HSI (i.e., similar directional response, but reduced magnitude).

Materials and Methods {#s1}
=====================

Ethical Approval
----------------

The Human Subjects Institutional Review Board of the University of Delaware approved this study (HS\#05-147). Participants gave written consent prior to participation. This study conformed to the standards set by the Declaration of Helsinki; however, this physiology study was not registered.

Participants
------------

Thirty-nine participants with normal resting BP were recruited--19 African Americans (9 males and 10 females) and 20 Caucasians (15 males and 5 females)--for the study. Only participants that self-reported both parents as Caucasian or both parents as African American were included in the study.

Screening Visit
---------------

All participants filled out a Physical Activity Readiness Questionnaire and medical history form ([@B13]). A fasting blood sample was taken to measure liver enzymes (alanine aminotranferase; ALT and aspartate aminotransferase; AST), kidney function (creatinine and blood urea nitrogen; BUN), a lipid profile, fasting glucose, and electrolytes, and a complete blood count. Height and weight were measured and body mass index (BMI) was calculated. Body fat percent was estimated using the skin fold technique ([@B13]). Resting BP and ECG were measured (GE Dash 2000 GE Medical Systems, Milwaukee, WI, United States).

Experimental Visit
------------------

To ensure adequate hydration, participants were instructed to drink 600 ml of water during the morning, mid-day, and night the day before the experimental visit, and another 600 ml of water the morning of the experimental visit. Participants were instructed to avoid table salt and foods that are high in sodium for 24 h preceding the experimental visit, and were provided a list of common foods that are high in Na^+^ to avoid ([@B43]; [@B38], [@B36], [@B39]; [@B5]; [@B37]). They were also instructed to avoid caffeine, exercise, and alcohol for at least 12 h before the visit. Females were tested during the early follicular phase of the menstrual cycle (self-reported). Upon arrival, participants emptied their bladder and a urine sample was collected to measure specific gravity (TS Meter Hand-held Refractometer, Reichert Inc., Depew, NY, United States) to confirm adequate hydration, and to rule out pregnancy in female participants (hCG rapid one-step test, Mainline Technology, Ann Arbor, Michigan). Participants were then equipped for measurement of single lead ECG, and oscillometric brachial BP. BP was taken in triplicate. A finger cuff was placed for analysis of beat-by-beat BP via servo-controlled photoplethysmography (Finometer, Finapres Medical Systems, Netherlands). An intravenous catheter was placed in the left arm for the HSI and the right arm for blood draws. The HSI is a large Na^+^ and volume load, which has been shown to cause an increase in plasma Na^+^ concentration and osmolality over a short period of time ([@B10], [@B11]; [@B50]; [@B15]).

Experimental Protocol
---------------------

At baseline, Finometer derived BP and HR were measured during 5 min of paced breathing at 0.25 Hz, and a blood sample was obtained. After baseline, a 60-min HSI began at a rate of 0.15 ml/kg/min. BP and HR were measured during 5 min of paced breathing, every 20 min into the HSI. Blood was drawn and analyzed for electrolytes, osmolality and hematocrit every 15 min and for PRA, Ang II, Aldo, and NE every 30 min.

Blood Analysis
--------------

Blood was drawn and placed in: (1) aprotinin-treated 4°C EDTA-sodium metabisulfite vacutainers for analysis of plasma NE; (2) K3 EDTA containing vacutainers for the analysis of PRA, plasma Ang II, Aldo, osmolality and hematocrit; and (3) no-additive vacutainers for the analysis of serum Na^+^. Whole blood samples were spun at 450 × *g* for 15 min at 4°C for separation of serum and plasma (Allegra X-22R, Beckman Coulter). Whole blood was placed into capillary tubes (Clay Adams Brand, Becton Dickinson, Parsippany, NJ, United States) and spun in a microcentrifuge to measure hematocrit. Plasma osmolality (model 3D3 Osmometer, Advanced Instruments, Norwood, MA, United States) and serum electrolytes (EasyElectrolytes Analyzer, Medica, Bedford, MA, United States) were measured immediately. The remaining plasma samples were frozen at -80°C for future analysis of NE, PRA, Ang II, and Aldo. NE was analyzed by HPLC at the Mayo Clinic Mayo Medical Laboratories and the RAAS hormones were analyzed by radioimmunoassay at the Wake Forest University Biomarker Analytical Core. The study design involved placing two intravenous catheters. We did not successfully place bilateral catheters in all participants. In cases in which only one catheter was placed, we used this I.V. catheter for HSI. Other difficulties included inadequate sample volume and cracked tubes. Therefore, not all blood samples were analyzed. The total number of participants reported for hormone data are listed in each figure legend. All samples were analyzed in triplicate. Statistics were run on plasma volume-corrected hormone concentrations (further detail below).

Data Analysis
-------------

ECG and BP were recorded by WinDaq recording software (DATAQ Instruments, Akron, OH, United States). The respective signal peaks were detected for determination of HR and BP. Upper-arm BP was taken to confirm Finometer-derived BP at 20, 40, and 60 min during the HSI. Hormones were corrected for the infusion-induced increase in plasma volume by multiplying the hormone values by the percent change in plasma volume \[calculated from hematocrit ([@B46])\] at 30 and 60 min. Based on our previous HSI studies ([@B10], [@B11]; [@B50]; [@B15]), we categorized changes in serum Na^+^ of \<3 mmol/L as *moderate*, 3--5 mmol/L as *intermediate*, and \>5 mmol/L as *large*.

Statistical Analysis
--------------------

All data were reported as mean ± SEM. Independent sample *t*-tests were used to analyze baseline racial differences in participants, and differences in peak responses \[change scores (Δ) relative to baseline values\]. Alternatively, when baseline differences in measures existed, the respective baseline value was used as a covariate and analyzed using ANCOVA. Two-way ANOVA was used to examine main effects of time and race for responses during the HSI. *Post hoc* analysis was completed using Tukey's HSD when appropriate (significant omnibus *F*). A mixed model analysis was used to assess the relation between race and serum Na^+^ systolic BP. SBP was set as the dependent variable, race was used as the fixed effect, and serum Na^+^ as a covariate. Categorical data were analyzed by the Pearson's chi-square test (goodness of fit). For all parametric statistical tests, the data was screened for conformity to required statistical assumptions. The α was set at 0.05 for all outcome measures. Statistical analyses were completed using IBM SPSS (24.0).

Results
=======

Participant characteristics are presented in **Table [1](#T1){ref-type="table"}**. African American participants had a lower BUN compared to Caucasian participants. However, the values were within clinically acceptable limits.

###### 

Participant characteristics. Racial differences compared using independent *t*-tests.

  Variable                African American   Caucasian     
  ----------------------- ------------------ ------------- -------
  Age (years)             23 ± 1             25 ± 1        0.289
  Sex (F/M)               (10/9)             (5/15)        0.071
  SBP (mmHg)              117 ± 2            120 ± 3       0.454
  DBP (mmHg)              73 ± 2             74 ± 2        0.514
  BMI (kg/m^2^)           25.7 ± 0.8         24.0 ± 0.7    0.264
  Body fat (%)            16.8 ± 1.7         15.5 ± 1.4    0.559
  Cholesterol (mg/dL)     182 ± 7            180 ± 8       0.898
  HDL (mg/dL)             62 ± 4             60 ± 3        0.815
  LDL (mg/dL)             105 ± 6            102± 7        0.687
  Triglycerides (mg/dL)   74 ± 9             92 ± 8        0.145
  Glucose (mg/dL)         86 ± 2             86 ± 2        0.754
  Creatinine (mg/dL)      0.98 ± 0.05        1.05 ± 0.04   0.368
  BUN (mg/dL)             11.8 ± 0.5         15.3 ± 1.0    0.004
  ALT (unit/L)            29.2 ± 2.9         32.9 ± 3.5    0.425
  AST (unit/L)            27.7 ± 2.3         31.1 ± 2.2    0.292

The proportion of females in the African American cohort was 53% compared to 25% in the Caucasian cohort. Sex distribution was compared using non-parametric testing and was not statistically different (*p* = 0.07). Participants were well matched for all other variables. There were not differences in urine specific gravity between the groups suggesting hydration status was not a confounding factor (1.020 ± 0.002 in African American individuals vs. 1.015 ± 0.002 in Caucasian individuals, *p* = 0.09). Estimated glomerular filtration rate was calculated from serum creatinine using the CKD-EPI equation and was normal (\>90 mL/min/1.73 m^2^) in both groups ([@B40]).

The HSI provided a robust stimulus, as demonstrated by increases in serum Na^+^, plasma osmolality, systolic and diastolic BP, and heart rate in both groups, while hematocrit decreased (**Table [2](#T2){ref-type="table"}**, all *p* \< 0.001). Of note, the peak Na^+^ change in African American participants was greater compared to Caucasian participants (Δ5.8 ± 0.3 vs. Δ4.8 ± 0.3; *p* = 0.03). There was also a significant interaction effect for systolic BP (*p* = 0.05). The peak systolic BP was Δ23.2 ± 2.6 in African American participants compared to Δ16.4 ± 2.5 in Caucasian participants (*p* = 0.07).

###### 

Cardiovascular responses to hypertonic saline infusion. Statistical comparisons made using two-way ANOVA.

  Variable               Race               Baseline      HSI time-pt. 1   HSI time-pt. 2   HSI time-pt. 3   Statistics
  ---------------------- ------------------ ------------- ---------------- ---------------- ---------------- ---------------------------
  Serum Na^+^ (mmol/L)   African American   134.0 ± 0.3   136.9 ± 0.4      139.5 ± 0.4      139.8 ± 0.4      time (*p* \< 0.001)
                         Caucasian          135.1 ± 0.6   137.3 ± 0.4      139.8 ± 0.4      139.9 ± 0.3      race (*p* = 0.387)
                                                                                                             interaction (*p* = 0.293)
  Plasma Osm (mOsm/kg)   African American   285.8 ± 0.8   290.4 ± 0.8      294.2 ± 0.9      295.5 ± 0.9      time (*p* \< 0.001)
                         Caucasian          288.4 ± 0.6   291.8 ± 0.6      296.1 ± 0.6      297.3 ± 0.5      race (*p* = 0.069)
                                                                                                             interaction (*p* = 0.293)
  Hematocrit (%)         African American   39.7 ± 1.0    37.7 ± 1.0       36.0 ± 1.0       36.1 ± 1.0       time (*p* \< 0.001)
                         Caucasian          40.6 ± 0.8    38.1 ± 0.7       36.8 ± 0.7       36.3 ± 0.7       race (*p* = 0.546)
                                                                                                             interaction (*p* = 0.248)
  Systolic BP (mmHg)     African American   124.0 ± 3.1   136.1 ± 3.2      143.9 ± 3.4      147.2 ± 3.9      time (*p* \< 0.001)
                         Caucasian          124.8 ± 3.3   133.0 ± 4.0      139.5 ± 4.3      141.2 ± 4.9      race (*p* = 0.542)
                                                                                                             interaction (*p* = 0.054)
  Diastolic BP (mmHg)    African American   63.4 ± 2.4    64.3 ± 2.5       68.3 ± 2.4       70.5 ± 2.6       time (p \< 0.001)
                         Caucasian          63.6 ± 2.1    63.4 ± 2.2       66.9 ± 2.1       68.0 ± 2.2       race (*p* = 0.708)
                                                                                                             interaction (*p* = 0.424
  Heart rate (bpm)       African American   60.4 ± 1.8    61.8 ± 1.9       62.0 ± 1.9       64.3 ± 1.9       time (*p* \< 0.001)
                         Caucasian          60.1 ± 1.6    60.7 ± 1.6       61.5 ± 1.6       63.2 ± 1.8       race (*p* = 0.752)
                                                                                                             interaction (*p* = 0.863)

During the HSI, BP responses were significantly influenced by both race (*p* = 0.02) and serum Na^+^ (*p* \< 0.001) (**Figure [1](#F1){ref-type="fig"}**; mixed model analysis). There was also a significant interaction between race and serum Na^+^ (*p* = 0.02). These data demonstrate an upward shift in the relation between serum Na^+^ and absolute systolic BP in African American adults. Categorical serum Na^+^ changes and corresponding changes in systolic BP throughout the HSI are presented in **Figure [2A](#F2){ref-type="fig"}**. There was a significant main effect for categorical serum Na^+^ changes (*p* = 0.008) and a significant main effect for group (*p* = 0.006) suggesting that as levels of serum sodium increased there was a greater increase in systolic BP, and that for a given categorical response in serum Na^+^, African American participants demonstrated a greater systolic BP response. Regarding categorical serum Na^+^ changes, 51% of African American participants had a "large" change in serum Na^+^ during HSI while 30% of Caucasian participants had a "large" change in serum Na^+^ during HSI (**Figure [2B](#F2){ref-type="fig"}**, *p* = 0.06).

![The influence of race and serum Na^+^ on systolic BP. At a given serum Na^+^, African American adults had a greater systolic BP. Statistically significant main effects and interaction listed on graph; all *p* \< 0.05. Data presented as mean ± SEM.](fphys-09-01354-g001){#F1}

![**(A)** Systolic BP changes corresponding to different categorical levels of changes in serum sodium; and **(B)** proportion of categorical serum sodium changes for African American and Caucasian participants. Statistically significant main or interaction effect where *p* \< 0.05. Data presented as mean ± SEM.](fphys-09-01354-g002){#F2}

The RAAS hormones were corrected for the expansion in plasma volume, and are presented in **Figure [3](#F3){ref-type="fig"}**. PRA and Aldo decreased throughout the HSI in both African American and Caucasian participants (see **Figures [3A,B](#F3){ref-type="fig"}**, top panel; *p* \< 0.01 main effect for time for both PRA and Aldo) and there was a significant main effect for race (*p* ≤ 0.001 for both). The peak reduction in PRA (*p* = 0.05) and Aldo (*p* = 0.03) from baseline to the end of the HSI (see **Figures [3A,B](#F3){ref-type="fig"}**, bottom panel) was greater in Caucasian participants when compared using an independent sample *t*-test. However, African American participants demonstrated lower baseline values of Aldo (*p* = 0.03) and there was a trend for lower PRA in African American participants compared to Caucasian participants (*p* = 0.07). Therefore, when the lower baseline PRA and Aldo for African American participants was factored in as a covariable, these differences were no longer statistically significant for either PRA (*p* = 0.56) or Aldo (*p* = 0.58). Regarding Ang II, there was not a significant main effect for time or race (**Figure [3C](#F3){ref-type="fig"}**, top panel). Further, the peak change in Ang II was not different between African American and Caucasian participants when compared using a *t*-test or ANCOVA (**Figure [3C](#F3){ref-type="fig"}**, bottom panel).

![Renin-angiotensin-aldosterone system (RAAS) response to HSI. **(A)** PRA (African American *n* = 16, Caucasian *n* = 12) measured at baseline and throughout the HSI (top panel) and peak responses (bottom); **(B)** Aldo (African American *n* = 18, Caucasian *n* = 20) measured at baseline and throughout the HSI (top panel) and peak responses (bottom); and **(C)** Ang II (African American *n* = 16, Caucasian *n* = 12) measured at baseline and throughout the HSI (top panel) and peak responses (bottom). African American participants are represented in closed circles (•) and Caucasian participants in open circles (∘). Statistically significant main or interaction effect where *p* \< 0.05. Data presented as mean ± SEM.](fphys-09-01354-g003){#F3}

Norepinephrine was not increased over the HSI (231.7 ± 20.8 -- 295.0 ± 34.6 pg/mL for African American adults and 218.0 ± 22.1 -- 251.1 ± 24.1 pg/mL for Caucasian adults; main effect for time, *p* = 0.114) and there were no racial differences in NE concentrations at baseline or throughout the HSI (main effect for group; *p* = 0.185). The peak change in NE was also not different between African American and Caucasian participants when compared using a *t*-test or ANCOVA.

Discussion
==========

The purpose of this study was to determine whether serum Na^+^, BP, and hormonal responses to an acute Na^+^ and volume load via HSI differ between young normotensive African American and Caucasian adults. The primary novel findings were that there was a significant interaction between race and absolute serum Na^+^ on systolic BP. For a given change in serum Na^+^ with the HSI, African American individuals demonstrated a greater increase in systolic BP. Further, African American individuals were more likely to demonstrate large increases in serum Na^+^ and displayed a greater peak change in serum Na^+^. These findings are of importance in light of (a) racial differences in the prevalence of salt-sensitive hypertension ([@B52]; [@B14]), and (b) the recent emphasis on plasma Na^+^ concentration and BP in the literature ([@B21]; [@B20]; [@B51]). Additionally, several studies indicate that a single high Na^+^ meal can similarly increase plasma Na^+^ ([@B8], [@B7]; [@B42]; [@B3]) and result in post-prandial reductions in endothelial functional ([@B8], [@B7]; [@B3]) and increases in BP ([@B42]). It has also been shown that young healthy African American females retain more Na^+^ than young Caucasian females when placed on a high salt diet ([@B30]). Thus, one may speculate that African American individuals could potentially be at greater risk for these negative post-prandial effects of increased plasma Na^+^, and over time, repeated exposure may contribute to the higher prevalence of salt-induced hypertension.

Consistent with the study hypothesis and previous literature ([@B27]), PRA and Aldo declined in response to the HSI; the decrease in PRA and Aldo was blunted in African American participants compared to Caucasian participants, indicating a less responsive RAAS in the face of an acute Na^+^ and volume load. However, this difference was no longer significant when we included the lower baseline PRA and Aldo values as covariables. Thus, it appears that not only the response of the RAAS is important, but also the baseline value, as there may be a floor effect due to this lower baseline. In other words, the lower baseline PRA and Aldo in African American individuals contribute to less of an absolute change in these hormones in response to Na^+^ challenges. It should be noted that previous studies reporting a greater reduction in PRA and Aldo in Caucasian cohorts compared to African American cohorts did not appear to use baseline values as covariables ([@B27]). This is an important consideration given that numerous studies have reported lower basal PRA and Aldo in African Americans individuals ([@B26]; [@B16]; [@B28]; [@B34]; [@B22], [@B23]), including a recent publication from the Multi-Ethnic Study of Atherosclerosis ([@B33]). Further, another recent study demonstrated greater reductions in PRA and Aldo with aging in African American individuals ([@B45]). Taken together with our data, this is physiologically and clinically relevant given the increased prevalence of hypertension, salt sensitive hypertension, and cardiovascular disease in African American adults as they age.

The cause of lower circulating levels of the RAAS in African American populations remains unclear. Interestingly, potassium supplementation has been shown to increase PRA in African American individuals, indicating some of the difference in RAAS hormones could be influenced by dietary intake ([@B31]). Thus, it would appear basal RAAS levels have important physiological consequences for buffering acute high Na^+^ challenges ([@B27]) and potentially chronic high Na^+^ diets ([@B28]). In addition to plasma RAAS concentrations, RAAS signaling at the tissue level has also been shown to play an important role in vascular health and disease. For example, increased intra-renal RAAS activity has been shown to contribute to an exaggerated reduction in renal plasma flow in healthy African American individuals compared to healthy Caucasian individuals during a high salt diet ([@B32]).

One potential cause for lower RAAS in African American populations could be greater Na^+^ retention and expanded extracellular fluid volume (resulting in similar serum Na^+^ compared to other populations). Indeed, a previous study has shown that African American individuals demonstrate greater total body water ([@B6]). Our participants were given the same instructions for Na^+^ and water intake for the day before the experimental visit. Baseline serum sodium values were similar between groups, and increased during the HSI (see **Table [2](#T2){ref-type="table"}**). For any given level of serum sodium, BP was greater in African American adults. Importantly, there was a significant main effect for categorical serum Na^+^ changes and a greater peak Na^+^ change with the HSI in African American participants, demonstrating that African American adults had higher serum Na^+^. Taken together, these findings suggest the African American participants had an impaired short-term ability to clear excess Na^+^. While we did not assess urinary Na^+^ excretion following the HSI, our findings are supported by a previous publication that reported African American individuals had reduced Na^+^ excretion in the first 12 h following an HSI compared to Caucasian individuals ([@B27]). Another study using incremental doses of salt for 3-day controlled diets found that African American individuals had reduced natriuresis compared to Caucasian individuals as dietary Na^+^ loads increased ([@B28]). Further, in recent years it has become appreciated that non-osmotic Na^+^ deposition in tissues (e.g., skin, muscle) also contributes to whole body Na^+^ balance and that sex and age influence tissue Na^+^ ([@B24]; [@B49]). To the best of our knowledge, the role of race in tissue Na^+^ deposition remains unstudied, but may have important consequences in Na^+^ regulation.

The sympathetic nervous system may also play an important role in the BP responses we observed in the current study. Although dietary Na^+^ increases sensitivity to sympathoexcitatory stimuli in rodents ([@B1]; [@B41]; [@B35]), the potential racial differences in humans remain unexplored. While we did not directly measure sympathetic nerve activity in this study, the HSI did not elicit a large increase in NE, an indirect measure of sympathetic outflow ([@B48]). There were no differences in NE observed between the African American and Caucasian participants at baseline or throughout the HSI. However, recent data suggest that African American individuals demonstrate greater sympathetic transduction ([@B47]). As noted in another recent study investigating racial differences in neural control of BP, habitual dietary patterns and stress (i.e., racial differences in allostatic load) could potentially influence racial differences in sympathetic BP regulation ([@B12]). Therefore, it could be that for a given increase in SNA, the African American participants in this study demonstrated a greater increase in BP. Unfortunately, we did not directly measure sympathetic outflow or blood flow to assess transduction. Therefore, this remains speculative but is supported by our previous findings that HSI increases sympathetic outflow ([@B11]; [@B50]) and the recent findings of heightened transduction in African American adults ([@B47]).

We recognize our study is not without limitations. Although we instructed participants to refrain from salty foods prior to the experimental visit, sodium intake was not strictly controlled (i.e., controlled feeding study). However, our focus was on the response to the acute hypertonic saline load. Additionally, all participants were given the same instructions as to Na^+^ and water intake for the day before and morning of the experimental visit. Second, we did not assess arginine vasopressin during the HSI, which has previously been shown to increase in response to HSI ([@B44]; [@B5]; [@B37]). Therefore, potential racial differences in arginine vasopressin could have contributed to our findings. Third, while the difference in sex distribution between the African American and Caucasian cohorts was not statistically significant, we recognize it could be meaningful. However, one might speculate the proportion of females in the African American cohort would lead to *less* BP responsiveness, as we have previously shown females are less susceptible to endothelial dysfunction following high dietary salt ([@B25]) and females demonstrate less salt sensitivity compared to male counterparts ([@B4]; [@B9]). Nonetheless, we observed greater BP responses for a given increase in serum sodium in the African American cohort. Finally, we also did not use an isovolumic isotonic control in this study. Importantly, we have previously shown that extracellular volume expansion alone does not elicit the same cardiovascular alterations that HSI does ([@B10], [@B11]). Nonetheless, we report potentially important racial differences in BP regulation in response to increases in serum Na^+^. Despite this, we cannot dismiss the possibility that racial differences exist in response to extracellular volume expansion alone.

In conclusion, acute increases in serum sodium via hypertonic saline resulted in greater BP responsiveness in African American participants for a given level of serum Na^+^. The ability to buffer the challenge may have been blunted in African American individuals due to a lower resting circulating levels of the RAAS. This resulted in less of a reduction in PRA and Aldo to the HSI. African American and Caucasian participants demonstrated a similar increase in NE; however recent evidence suggests there could be heightened sympathetic transduction in the African American participants ([@B47]). These findings are important as they suggest that African American individuals may not be able to buffer acute Na^+^ challenges as Caucasian individuals. These findings have important clinical implications: acute elevations in serum Na^+^ (i.e., post-prandial) have a negative impact on the health of the vasculature ([@B8], [@B7]; [@B42]; [@B3]), and our data demonstrate important racial differences in BP responsiveness. Thus, it is likely that repeated increases in BP responsiveness over time may contribute to the racial disparity in salt-sensitive hypertension.
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